IndraLab

Statements


USP35 increases the amount of Interferon. 1 / 1
| 1

reach
"Further studies revealed that USP35 overexpression decreased the activation of STING-TBK1-IRF3 pathway and reduced the expression of type I interferon, thus weakening the STING-mediated anti-tumor activity of type I interferon and promoting tumor growth."